176 related articles for article (PubMed ID: 38888887)
1. Unleashing the potential: type I CRISPR-Cas systems in actinomycetes for genome editing.
Wang S; Zeng X; Jiang Y; Wang W; Bai L; Lu Y; Zhang L; Tan GY
Nat Prod Rep; 2024 Jun; ():. PubMed ID: 38888887
[TBL] [Abstract][Full Text] [Related]
2. Dual-function chromogenic screening-based CRISPR/Cas9 genome editing system for actinomycetes.
Wang Q; Xie F; Tong Y; Habisch R; Yang B; Zhang L; Müller R; Fu C
Appl Microbiol Biotechnol; 2020 Jan; 104(1):225-239. PubMed ID: 31788711
[TBL] [Abstract][Full Text] [Related]
3. Application of different types of CRISPR/Cas-based systems in bacteria.
Liu Z; Dong H; Cui Y; Cong L; Zhang D
Microb Cell Fact; 2020 Sep; 19(1):172. PubMed ID: 32883277
[TBL] [Abstract][Full Text] [Related]
4. Endogenous CRISPR-Cas mediated in situ genome editing: State-of-the-art and the road ahead for engineering prokaryotes.
Liu Z; Liu J; Yang Z; Zhu L; Zhu Z; Huang H; Jiang L
Biotechnol Adv; 2023 Nov; 68():108241. PubMed ID: 37633620
[TBL] [Abstract][Full Text] [Related]
5. Application of Cas12j for
Tan LL; Heng E; Leong CY; Ng V; Yang LK; Seow DCS; Koduru L; Kanagasundaram Y; Ng SB; Peh G; Lim YH; Wong FT
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672502
[TBL] [Abstract][Full Text] [Related]
6. Expanding the plant genome editing toolbox with recently developed CRISPR-Cas systems.
Wada N; Osakabe K; Osakabe Y
Plant Physiol; 2022 Mar; 188(4):1825-1837. PubMed ID: 35099553
[TBL] [Abstract][Full Text] [Related]
7. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
[TBL] [Abstract][Full Text] [Related]
8. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
Briner AE; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Cas proteins for CRISPR-Cas editing in streptomycetes.
Yeo WL; Heng E; Tan LL; Lim YW; Lim YH; Hoon S; Zhao H; Zhang MM; Wong FT
Biotechnol Bioeng; 2019 Sep; 116(9):2330-2338. PubMed ID: 31090220
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed conditional genome editing with Cas12a in
Port F; Starostecka M; Boutros M
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348
[TBL] [Abstract][Full Text] [Related]
11. [Advances in utilizing the endogenous CRISPR-Cas system for genome editing of lactic acid bacteria].
Zhu Q; Xu C; Zhang S; Xie N; Pang X; Lü J
Sheng Wu Gong Cheng Xue Bao; 2022 Jul; 38(7):2447-2458. PubMed ID: 35871616
[TBL] [Abstract][Full Text] [Related]
12. Recent advances of Cas12a applications in bacteria.
Meliawati M; Schilling C; Schmid J
Appl Microbiol Biotechnol; 2021 Apr; 105(8):2981-2990. PubMed ID: 33754170
[TBL] [Abstract][Full Text] [Related]
13. Evolution of CRISPR/Cas Systems for Precise Genome Editing.
Hryhorowicz M; Lipiński D; Zeyland J
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762535
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
Manghwar H; Lindsey K; Zhang X; Jin S
Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the RNA-targeting CRISPR-Cas systems].
Hong T; Luo Q
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1363-1373. PubMed ID: 37154311
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cpf1-Assisted Multiplex Genome Editing and Transcriptional Repression in Streptomyces.
Li L; Wei K; Zheng G; Liu X; Chen S; Jiang W; Lu Y
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980561
[No Abstract] [Full Text] [Related]
17. Development of a CRISPR/Cas9
Ma JX; He WY; Hua HM; Zhu Q; Zheng GS; Zimin AA; Wang WF; Lu YH
ACS Synth Biol; 2023 Oct; 12(10):3114-3123. PubMed ID: 37722085
[TBL] [Abstract][Full Text] [Related]
18. Characterization and Repurposing of Type I and Type II CRISPR-Cas Systems in Bacteria.
Hidalgo-Cantabrana C; Goh YJ; Barrangou R
J Mol Biol; 2019 Jan; 431(1):21-33. PubMed ID: 30261168
[TBL] [Abstract][Full Text] [Related]
19. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
Ishino Y; Krupovic M; Forterre P
J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
[TBL] [Abstract][Full Text] [Related]
20. Challenges and Advances in Genome Editing Technologies in
Zhao Y; Li G; Chen Y; Lu Y
Biomolecules; 2020 May; 10(5):. PubMed ID: 32397082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
